United States · FDA National Drug Code directory
Topamax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50458-641_1c7483cf-95db-4b1c-ae4c-b11bc95a6ad8
- Product NDC
- 50458-641
- Form
- TABLET, COATED
- Composition / generic term
- topiramate
- Labeler
- Janssen Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 19970101
- Source listing expiry
- 20271231
Source-listed ingredients
- TOPIRAMATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, COATED in 1 BOTTLE (50458-641-65) · 50458-641-65
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →